WO2012017128A3 - Composition based on rosemary extract and vitamin e and uses thereof - Google Patents

Composition based on rosemary extract and vitamin e and uses thereof Download PDF

Info

Publication number
WO2012017128A3
WO2012017128A3 PCT/ES2011/070586 ES2011070586W WO2012017128A3 WO 2012017128 A3 WO2012017128 A3 WO 2012017128A3 ES 2011070586 W ES2011070586 W ES 2011070586W WO 2012017128 A3 WO2012017128 A3 WO 2012017128A3
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
rosemary extract
composition based
menopause
treating
Prior art date
Application number
PCT/ES2011/070586
Other languages
Spanish (es)
French (fr)
Other versions
WO2012017128A1 (en
WO2012017128A2 (en
Inventor
Enrique De Miguel Del Campo
Guillermo Reglero Rada
Carlota Largo Aramburu
Fornari Reale
Mónica RODRÍGUEZ GARCÍA-RISCO
Laura Jaime De Pablo
Susana Santoyo Diez
Francisco Javier SEÑORANS RODRÍGUEZ
Original Assignee
Universidad Autónoma de Madrid
Fundacion Para La Investigacion Biomedica Del Hospital Universitario De La Paz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Autónoma de Madrid, Fundacion Para La Investigacion Biomedica Del Hospital Universitario De La Paz filed Critical Universidad Autónoma de Madrid
Publication of WO2012017128A1 publication Critical patent/WO2012017128A1/en
Publication of WO2012017128A2 publication Critical patent/WO2012017128A2/en
Publication of WO2012017128A3 publication Critical patent/WO2012017128A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

The composition comprises a rosemary extract and vitamin E, and may be used as a nutritional supplement and also in the production of pharmaceutical compositions for reducing inflammatory processes and lipid peroxidation in general and, in particular, processes associated with the menopause, and also for preventing and/or treating the adverse effects of ionizing radiation.
PCT/ES2011/070586 2010-08-05 2011-08-05 Composition based on rosemary extract and vitamin e and uses thereof WO2012017128A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201031225A ES2374482B1 (en) 2010-08-05 2010-08-05 COMPOSITION FOR REDUCTION OF SYMPTOMS ASSOCIATED WITH MENOPAUSE.
ESP201031225 2010-08-05

Publications (3)

Publication Number Publication Date
WO2012017128A1 WO2012017128A1 (en) 2012-02-09
WO2012017128A2 WO2012017128A2 (en) 2012-02-09
WO2012017128A3 true WO2012017128A3 (en) 2012-03-08

Family

ID=45541172

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2011/070586 WO2012017128A2 (en) 2010-08-05 2011-08-05 Composition based on rosemary extract and vitamin e and uses thereof

Country Status (2)

Country Link
ES (1) ES2374482B1 (en)
WO (1) WO2012017128A2 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048919A1 (en) * 2002-07-02 2004-03-11 Dreon Darlene M. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20070141170A1 (en) * 2005-12-20 2007-06-21 Alcon Manufacturing, Ltd. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
US20070253941A1 (en) * 2006-04-28 2007-11-01 Naidu A Satyanarayan Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
WO2007141764A1 (en) * 2006-06-08 2007-12-13 The Iams Company Use of at least one polyphenol for promoting eye health
EP1902631A2 (en) * 2006-09-19 2008-03-26 Institut National de Recherche Agronomique Plant-based natural antioxidant additive intended for animal nutrition
WO2009136410A2 (en) * 2008-04-19 2009-11-12 Nisarga Biotech Pvt. Ltd. Herbal composition for reducing add/adhd and method thereof
US20100048512A1 (en) * 2006-12-01 2010-02-25 National Institute Of Radiological Sciences Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352712B1 (en) * 1999-04-30 2002-03-05 Daniel O. Lukaczer Dietary supplements for treating fatigue-related syndromes
NO20081487L (en) * 2008-03-27 2009-09-28 Smartfish As Health promoting drink
US20100178369A1 (en) * 2009-01-15 2010-07-15 Nicole Lee Arledge Antioxidant-stabilized concentrated fish oil

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048919A1 (en) * 2002-07-02 2004-03-11 Dreon Darlene M. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20070141170A1 (en) * 2005-12-20 2007-06-21 Alcon Manufacturing, Ltd. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
US20070253941A1 (en) * 2006-04-28 2007-11-01 Naidu A Satyanarayan Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
WO2007141764A1 (en) * 2006-06-08 2007-12-13 The Iams Company Use of at least one polyphenol for promoting eye health
EP1902631A2 (en) * 2006-09-19 2008-03-26 Institut National de Recherche Agronomique Plant-based natural antioxidant additive intended for animal nutrition
US20100048512A1 (en) * 2006-12-01 2010-02-25 National Institute Of Radiological Sciences Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient
WO2009136410A2 (en) * 2008-04-19 2009-11-12 Nisarga Biotech Pvt. Ltd. Herbal composition for reducing add/adhd and method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PENG, C.-H. ET AL.: "Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects.", BIOSCIENCE, BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 71, no. 9, 2007, pages 2223 - 2232 *

Also Published As

Publication number Publication date
ES2374482A1 (en) 2012-02-17
WO2012017128A2 (en) 2012-02-09
ES2374482B1 (en) 2012-12-27

Similar Documents

Publication Publication Date Title
WO2008153945A3 (en) Nutraceutical co-crystal compositions
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
WO2016086206A8 (en) Probiotic compositions containing clostridiales for inhibiting inflammation
WO2013177419A3 (en) Lipid nanoparticle compositions and methods of making and methods of using the same
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2014057362A3 (en) Omega -3 compositions
PH12015500756A1 (en) Methods for enhancing the effect of egcg on mitigating skeletal muscle loss
WO2012074930A3 (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
IN2015DN03069A (en)
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
PH12017500641A1 (en) Nutritional compositions comprising an oxidizablecomponent and water-soluble plant extract
WO2013150386A3 (en) Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
WO2015067336A3 (en) Conjugated polymers
PH12014500859A1 (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
EP2575842A4 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
MX2017009929A (en) Compositions and methods for improved muscle metabolism.
MY155615A (en) Nutritional compositions comprising fruit flakes containing docosahexaenoic acid
WO2013100718A3 (en) Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
WO2015073177A8 (en) Vaginal inserted estradiol pharmaceutical compositons and methods
WO2012134172A3 (en) Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity
WO2013037985A8 (en) Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2012036414A3 (en) Cosmetic composition comprising a fermented soybean extract fraction as an active ingredient
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2